Concepedia

Ashwini M. Londhe

AM

11

Publications

527

Citations

11

H-Index

2014

Active since

Affiliations

Convergence Research Center for Diagnosis Treatment and Care System of Dementia(Current)

Korea Institute of Science and Technology

Korea University of Science and Technology

Bio-Medical Science (South Korea)

Kyung Hee University

Ashwini M. Londhe is an author at Convergence Research Center for Diagnosis Treatment and Care System of Dementia specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2014–2021

11

Publications

11

Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease

Jong‐Hyun Park, Yeon Ha Ju, Ji Won Choi et al. · Science Advances · 2019 · 198 citations · Full text

Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model

Siwon Kim, Ambily Nath Indu Viswanath, Jong‐Hyun Park et al. · Neuropharmacology · 2020 · 106 citations

, , +10

Investigation of Molecular Details of Keap1-Nrf2 Inhibitors Using Molecular Dynamics and Umbrella Sampling Techniques

Ashwini M. Londhe, Changdev G. Gadhe, Sang Min Lim et al. · Molecules · 2019 · 62 citations · Full text

, , +18

Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders

Ahmed Karam Farag, Ahmed Elkamhawy, Ashwini M. Londhe et al. · European Journal of Medicinal Chemistry · 2017 · 33 citations · Full text

, , +10

Discovery of<i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B

Ahmed Elkamhawy, Sora Paik, Hyeon Jeong Kim et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2020 · 29 citations · Full text

Rows per page

1–5 of 11